ETFs in Focus on Eli Lilly’s Solid Q2 Earnings, Weak Obesity Data
Eli Lilly and Company LLY reported robust second-quarter 2025 results, wherein it beat estimates on both the top…
Daniel Drucker, Ozempic’s father: ‘I’m very conservative. I don’t sell the drugs. I study the drugs’ | Health
Daniel Drucker, 68, speaks a little Spanish at the BBVA Foundation headquarters in Bilbao, Spain, where he’s about…